Adaptimmune Therapeutics PLC (NASDAQ:ADAP)

5.05
Delayed Data
As of Apr 09
 -0.085 / -1.66%
Today’s Change
2.83
Today|||52-Week Range
13.40
-6.40%
Year-to-Date
No recent news for Adaptimmune Therapeutics PLC.

Today’s Trading

Previous close5.13
Today’s open5.03
Day’s range4.99 - 5.37
Volume27,961
Average volume (3 months)1,309,057
Market cap$854.8M
Data as of 3:59pm ET, 04/09/2021

Growth & Valuation

Earnings growth (last year)+29.87%
Earnings growth (this year)-550.00%
Earnings growth (next 5 years)+5.60%
Revenue growth (last year)+254.04%
P/E ratioNM
Price/Sales192.51
Price/Book2.50

Competitors

----
HARPHarpoon Therapeutics...+0.07+0.31%
EPZMEpizyme Inc-0.07-0.83%
VBIVVBI Vaccines Inc-0.07-2.44%
Data as of 4:00pm ET, 04/09/2021

Financials

Next reporting dateMay 12, 2021
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$4.0M
Annual profit (last year)-$131.1M
Net profit margin-3,286.81%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Abingdon, Oxfordshire

Forecasts